A Systematic Review Concerning the Relation between the Sympathetic Nervous System and Heart Failure with Preserved Left Ventricular Ejection Fraction

Background Heart failure with preserved left ventricular ejection fraction (HFPEF) affects about half of all patients diagnosed with heart failure. The pathophysiological aspect of this complex disease state has been extensively explored, yet it is still not fully understood. Since the sympathetic nervous system is related to the development of systolic HF, we hypothesized that an increased sympathetic nerve activation (SNA) is also related to the development of HFPEF. This review summarizes the available literature regarding the relation between HFPEF and SNA. Methods and Results Electronic databases and reference lists through April 2014 were searched resulting in 7722 unique articles. Three authors independently evaluated citation titles and abstracts, resulting in 77 articles reporting about the role of the sympathetic nervous system and HFPEF. Of these 77 articles, 15 were included for critical appraisal: 6 animal and 9 human studies. Based on the critical appraisal, we selected 9 articles (3 animal, 6 human) for further analysis. In all the animal studies, isoproterenol was administered to mimic an increased sympathetic activity. In human studies, different modalities for assessment of sympathetic activity were used. The studies selected for further evaluation reported a clear relation between HFPEF and SNA. Conclusion Current literature confirms a relation between increased SNA and HFPEF. However, current literature is not able to distinguish whether enhanced SNA results in HFPEF, or HFPEF results in enhanced SNA. The most likely setting is a vicious circle in which HFPEF and SNA sustain each other.

[1]  H. Verberne,et al.  For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. , 2014, European heart journal cardiovascular Imaging.

[2]  A. de la Sierra,et al.  Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance , 2014, Journal of Human Hypertension.

[3]  T. Yonezawa,et al.  Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats , 2014, Cardiovascular Diabetology.

[4]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[5]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[6]  T. Nakata,et al.  A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. , 2013, JACC. Cardiovascular imaging.

[7]  L. Bortolotto,et al.  High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients. , 2013, American journal of hypertension.

[8]  W. Verloop,et al.  Ischemia and Reactive Oxygen Species in Sympathetic Hyperactivity States: A Vicious Cycle that can be Interrupted by Renal Denervation? , 2013, Current Hypertension Reports.

[9]  R. Wachter,et al.  Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. , 2013, JAMA.

[10]  F. Kajiya,et al.  Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[11]  E. Vink,et al.  Sympathetic Hyperactivity in Chronic Kidney Disease: Pathophysiology and (New) Treatment Options , 2013, Current Hypertension Reports.

[12]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[13]  吉川 和歌子,et al.  Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophied rat hearts induced by chronic β-adrenergic stimulation , 2013 .

[14]  N. de Las Heras,et al.  Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum‐ and glucocorticoid‐regulated kinase type 1 , 2012, Experimental physiology.

[15]  M. Böhm,et al.  Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. , 2012, Journal of the American College of Cardiology.

[16]  P. Vardas,et al.  Effects of the long‐term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study , 2012, European journal of heart failure.

[17]  M. Frenneaux,et al.  Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study , 2012, European journal of heart failure.

[18]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[19]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[20]  A. Riolobos,et al.  Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice. , 2011, Free radical biology & medicine.

[21]  F. Cacciapuoti Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. , 2011, Journal of the American Society of Hypertension : JASH.

[22]  S. Fröhling,et al.  Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. , 2011, Journal of the American College of Cardiology.

[23]  Q. Shen,et al.  Distinct actions of intermittent and sustained β-adrenoceptor stimulation on cardiac remodeling , 2011, Science China Life Sciences.

[24]  B. Borlaug,et al.  Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum , 2011, Circulation.

[25]  W. Paulus,et al.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. , 2011, European heart journal.

[26]  S. Malpas Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. , 2010, Physiological Reviews.

[27]  Akshay S. Desai,et al.  The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis. , 2010, Journal of cardiac failure.

[28]  J. S. Janicki,et al.  Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive Heart , 2010, Hypertension.

[29]  J. Bronzwaer,et al.  Diastolic and systolic heart failure: Different stages or distinct phenotypes of the heart failure syndrome? , 2009, Current heart failure reports.

[30]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[31]  R. Wachter,et al.  Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure , 2009, European heart journal.

[32]  C. H. Conrad,et al.  Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. , 2009, Comparative medicine.

[33]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[34]  A. Cohen-Solal,et al.  Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). , 2009, Journal of the American College of Cardiology.

[35]  D. Kitzman,et al.  Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure. , 2009, Congestive heart failure.

[36]  G. Mancia,et al.  Sympathetic and Baroreflex Cardiovascular Control in Hypertension-Related Left Ventricular Dysfunction , 2009, Hypertension.

[37]  C. Rosendorff The chicken and the egg: sympathetic nervous system activity and left ventricular diastolic dysfunction. , 2009, Hypertension.

[38]  W. Young,et al.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[39]  J. Wess,et al.  Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. , 2008, American journal of physiology. Heart and circulatory physiology.

[40]  S. Mizutani,et al.  Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies , 2008, Heart Failure Reviews.

[41]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[42]  A. Hoes,et al.  Clinical epidemiology of heart failure , 2007, Heart.

[43]  Mahipal Singh,et al.  &bgr;1 Integrins Modulate &bgr;-Adrenergic Receptor–Stimulated Cardiac Myocyte Apoptosis and Myocardial Remodeling , 2007, Hypertension.

[44]  T. Takano,et al.  Relationship between plasma norepinephrine at peak exercise and 123I-MIBG imaging of the heart and lower limbs in heart failure. , 2007, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[45]  R. McKelvie,et al.  Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. , 2007, Journal of the American College of Cardiology.

[46]  M. Lohse,et al.  Interstitial remodeling in β1-adrenergic receptor transgenic mice , 2006, Basic Research in Cardiology.

[47]  D. Kass,et al.  Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction , 2006, Circulation.

[48]  T. Fukutomi,et al.  The relationship between variables of 123-I-metaiodobenzylguanidine cardiac imaging and clinical status of the patients with diastolic heart failure. , 2006, International journal of cardiology.

[49]  G. Germanó,et al.  Autonomic cardiovascular control and diastolic dysfunction in hypertensive subjects. , 2006, International journal of cardiology.

[50]  H. Katus,et al.  Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats. , 2006, Endocrinology.

[51]  A. Leite-Moreira,et al.  Current perspectives in diastolic dysfunction and diastolic heart failure , 2006, Heart.

[52]  Matthias Dütsch,et al.  Quantitative studies of autonomic function , 2006, Muscle & nerve.

[53]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[54]  J. McMurray,et al.  Neurohumoral pathways in heart failure with preserved systolic function. , 2005, Progress in cardiovascular diseases.

[55]  T. Iwasaka,et al.  Iodine 123‐metaiodobenzylguanidine imaging reflect generalized sympathetic activation in patients with left ventricular dysfunction , 2005, Clinical physiology and functional imaging.

[56]  B. Wallin,et al.  Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade , 1993, Clinical Autonomic Research.

[57]  W. Gaasch,et al.  Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. , 2004, The New England journal of medicine.

[58]  S. Jackson Diastolic heart failure , 2004, BMJ : British Medical Journal.

[59]  T. LeJemtel,et al.  Heart Rate Variability and Diastolic Heart Failure , 2004, Pacing and clinical electrophysiology : PACE.

[60]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[61]  Jeffrey C. Hill,et al.  Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. , 2003, The American journal of cardiology.

[62]  M. Zile Heart failure with preserved ejection fraction: is this diastolic heart failure? , 2003, Journal of the American College of Cardiology.

[63]  P. Blankestijn,et al.  Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. , 2003, Journal of the American Society of Nephrology : JASN.

[64]  J. Kooner,et al.  Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. , 2002, Journal of the American College of Cardiology.

[65]  P. Doevendans,et al.  Diagnosing diastolic heart failure , 2002, European journal of heart failure.

[66]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.

[67]  A. Iskandrian,et al.  MIBG imaging , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[68]  I. Kubota,et al.  Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral β2-adrenoceptor agonists , 2001 .

[69]  I. Kubota,et al.  Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoceptor agonists. , 2001, American heart journal.

[70]  P. Blankestijn,et al.  ENALAPRIL AND LOSARTAN ARE EQUALLY EFFECTIVE IN REDUCING SYMPATHETIC HYPERACTIVITY IN CHRONIC RENAL FAILURE: P2.3 , 2000 .

[71]  B. Chandrasekar,et al.  Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. , 2000, Circulation.

[72]  H. Schunkert,et al.  Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. , 1998, Cardiovascular research.

[73]  U. Nixdorff,et al.  Beta-adrenergic stimulation enhances left ventricular diastolic performance in normal subjects. , 1997, Journal of cardiovascular pharmacology.

[74]  B. Strauer,et al.  Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients , 1996, Journal of hypertension.

[75]  A. Quyyumi,et al.  Cardiac sympathetic nerve function in congestive heart failure. , 1996, Circulation.

[76]  K J Osterziel,et al.  Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1996, Circulation.

[77]  G. Grassi,et al.  Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1995, Circulation.

[78]  I. Meredith,et al.  Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. , 1990, Physiological reviews.

[79]  A. Marmor,et al.  A single dose of cilazapril improves diastolic function in hypertensive patients. , 1989, The American journal of medicine.

[80]  K. White,et al.  Clinical epidemiology. , 1983, International journal of epidemiology.